AURYZON BY RECONSTRATA

  • Home
  • About Us
  • Donate
  • AuryzoN
  • Humanitarian Ambassadors
  • For Investors
  • Contact
  • Home
  • About Us
  • Donate
  • AuryzoN
  • Humanitarian Ambassadors
  • For Investors
  • Contact

For Investors

Our current goal: Early phase human clinical trials


Funding stage: Seed

AuryzoN currently exists as a prototype, which has demonstrated exciting results, with significant improvement in reconstructive quality, with upwards of 85-90% of time reduction in framework development as compared to the current gold standard of therapy.

​This device demonstrates a high degree of value for institutions and practices that perform facial cartilaginous reconstructive procedures. Furthermore, AuryzoN (and its sister device, DimensioN) are simple, easy-to-use, and non-electronic devices, which reduce device complexity in the setting of maintenance and troubleshooting, and are furthermore perfectly designed for use in medical missions domestically and abroad.

AuryzoN is poised to become a new gold standard therapy for facial cartilaginous reconstructions of ears, noses, and eyelids for patients affected by congenital deformities, trauma, cancer, or infection. 

ReconstratA is honored to have had the support of its many supporters through personal donations, and those through Kickstarter, as well as the generous support of the Limitless Tomorrow Foundation. 

Our company continues to grow and advance, and we are excited to continue propelling AuryzoN into the future!

Collision ALPHA Class of 2016

ReconstratA was selected from over 60,000 startups to present as part of the ALPHA Class at the 2016 Collision Conference in New Orleans. 
Collision

​​Kickstarter

Our campaign was successfully funded, raising over $30,000 towards the development of AuryzoN! Thank you to all of our supporters!
Kickstarter Campaign

Contact Us

Please contact us directly with any questions or for more information regarding our company or product.
Contact Us